Robert Irving Fox

Robert Irving Fox's AcademicInfluence.com Rankings

Robert Irving Fox

Philosophy

#8174

World Rank

#11503

Historical Rank

Logic

#5204

World Rank

#6585

Historical Rank

philosophy Degrees

Robert Irving Fox

Biology

#11025

World Rank

#14399

Historical Rank

Immunology

#704

World Rank

#726

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Robert Irving Fox's Degrees

PhD Immunology University of California, San Francisco
Doctorate Medicine Stanford University

Why Is Robert Irving Fox Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Robert Irving Fox's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. (1999) (2159)
Sjögren's syndrome (1995) (833)
The pathology of dry eye: the interaction between the ocular surface and lacrimal glands. (1998) (806)
Sjögren's syndrome. Proposed criteria for classification. (1986) (691)
Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge (2008) (594)
Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome. (1994) (422)
Detection of Epstein-Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjogren's syndrome (1989) (390)
Primary Sjogren syndrome: clinical and immunopathologic features. (1984) (365)
Studies of a human T lymphocyte antigen recognized by a monoclonal antibody. (1980) (355)
A distinct endothelial cell recognition system that controls lymphocyte traffic into inflamed synovium. (1986) (318)
Decreased angiogenesis and arthritic disease in rabbits treated with an αvβ3 antagonist (1999) (311)
Immunohistologic analysis of lymphoid infiltrates in primary Sjogren's syndrome using monoclonal antibodies. (1983) (301)
Update in Sjögren syndrome. (2000) (273)
Human T-lymphocyte activation is associated with changes in O-glycan biosynthesis. (1988) (273)
Two new monoclonal antibodies (LN-1, LN-2) reactive in B5 formalin-fixed, paraffin-embedded tissues with follicular center and mantle zone human B lymphocytes and derived tumors. (1984) (245)
Detection of Epstein-Barr virus-associated antigens and DNA in salivary gland biopsies from patients with Sjogren's syndrome. (1986) (221)
Synovial fluid lymphocytes differ from peripheral blood lymphocytes in patients with rheumatoid arthritis. (1982) (216)
A human thymus-leukemia antigen defined by hybridoma monoclonal antibodies. (1979) (198)
Immunohistologic characterization of synovial membrane lymphocytes in rheumatoid arthritis. (1984) (194)
Epstein-Barr virus induces aggressive lymphoproliferative disorders of human B cell origin in SCID/hu chimeric mice. (1990) (167)
Rheumatoid factor and immune networks. (1987) (162)
Dissociation of immune responses to the SS-A (Ro) 52-kd and 60-kd polypeptides in systemic lupus erythematosus and Sjögren's syndrome. (1990) (155)
Pathogenesis of Sjögren's syndrome. (1992) (151)
Criteria for diagnosis of Sjögren's syndrome. (1994) (135)
Use of monoclonal antibodies to analyze peripheral blood and salivary gland lymphocyte subsets in Sjögren's syndrome. (1982) (128)
Decreased angiogenesis and arthritic disease in rabbits treated with an alphavbeta3 antagonist. (1999) (123)
A unified theory of the role of the ocular surface in dry eye. (1998) (123)
Treatment of primary Sjögren's syndrome with hydroxychloroquine. (1988) (119)
Early diagnosis of primary Sjögren’s syndrome: EULAR-SS task force clinical recommendations (2016) (116)
Use of muscarinic agonists in the treatment of Sjögren's syndrome. (2001) (108)
Current issues in the diagnosis and treatment of Sjögren's syndrome. (1999) (108)
Expression of histocompatibility antigen HLA-DR by salivary gland epithelial cells in Sjögren's syndrome. (1986) (104)
Mechanism of Action of Antimalarial Drugs: Inhibition of Antigen Processing and Presentation (1993) (103)
Expression of a cross-reactive idiotype on rheumatoid factor in patients with Sjogren's syndrome. (1986) (98)
Treatment Guidelines for Rheumatologic Manifestations of Sjögren's Syndrome: Use of Biologic Agents, Management of Fatigue, and Inflammatory Musculoskeletal Pain (2017) (94)
The inhibition of phagocytosis and facilitation of exocytosis in rabbit polymorphonuclear leukocytes by cytochalasin B. (1973) (91)
High frequency of t(14;18) translocation in salivary gland lymphomas from Sjogren's syndrome patients (1991) (90)
First international symposium on Sjögren's syndrome: suggested criteria for classification. (1986) (89)
Clinical features, pathogenesis, and treatment of Sjögren's syndrome. (1996) (85)
Potential role of Epstein-Barr virus in Sjögren's syndrome and rheumatoid arthritis. (1992) (81)
Expression and regulation of the neural cell adhesion molecule L1 on human cells of myelomonocytic and lymphoid origin. (1997) (80)
Rheumatoid arthritis synovial membrane contains a 62,000-molecular-weight protein that shares an antigenic epitope with the Epstein-Barr virus-encoded associated nuclear antigen. (1986) (79)
T-lymphocytic leukemia expresses complex, branched O-linked oligosaccharides on a major sialoglycoprotein, leukosialin. (1991) (79)
Expression of three cross-reactive idiotypes on rheumatoid factor autoantibodies from patients with autoimmune diseases and seropositive adults. (1986) (78)
Approaches to the treatment of Sjögren's syndrome. (2000) (78)
Pathogenesis and treatment of Sjögren's syndrome. (1997) (76)
Estrogen in autoimmunity: expression of estrogen receptors in thymic and autoimmune T cells. (1999) (72)
DETECTION OF CLONALLY EXPANDED SALIVARY GLAND LYMPHOCYTES IN SJÖGREN'S SYNDROME (1989) (72)
Molecular characterization of a major autoantibody-associated cross-reactive idiotype in Sjogren's syndrome. (1989) (66)
T gamma cells express T lymphocyte-associated antigens. (1981) (66)
Production of interleukin 2 (IL 2) by salivary gland lymphocytes in Sjögren's syndrome. Detection of reactive cells by using antibody directed to synthetic peptides of IL 2. (1985) (65)
Sjögren's syndrome in dermatology. (2006) (65)
Sjögren's syndrome: mechanisms ofpathogenesis involve interaction of immune and neurosecretory systems (2002) (62)
Elevation of von Willebrand factor is independent of erythrocyte sedimentation rate and persists after glucocorticoid treatment in giant cell arteritis. (1984) (61)
Sjögren's syndrome. (1994) (61)
Lymphocyte phenotype and function in pseudolymphoma associated with Sjögren's syndrome. (1983) (55)
Sjögren's syndrome: mechanisms of pathogenesis involve interaction of immune and neurosecretory systems (2002) (55)
A novel cell surface antigen (T305) found in increased frequency on acute leukemia cells and in autoimmune disease states. (1983) (51)
Studies of HIV infection and the development of Epstein-Barr virus-related B cell lymphomas following transfer of human lymphocytes to mice with severe combined immunodeficiency. (1989) (51)
T cell attractant chemokine expression initiates lacrimal gland destruction in nonobese diabetic mice. (1999) (49)
Evolving concepts of diagnosis, pathogenesis, and therapy of Sjögren's syndrome. (1998) (49)
Expression of granzyme A in salivary gland biopsies from patients with primary Sjögren's syndrome. (1994) (47)
Classification criteria for Sjogren's syndrome: nothing ever stands still! (2013) (47)
Comparison of T cell receptor gene rearrangements in patients with large granular T cell leukemia and Felty's syndrome. (1987) (46)
Antiphospholipid antibodies and HLA associations in primary Sjögren's syndrome. (1992) (45)
T lymphocyte-mediated cytotoxicity against autologous EBV-genome-bearing B cells. (1981) (44)
Salivary gland lymphocytes in primary Sjogren's syndrome lack lymphocyte subsets defined by Leu-7 and Leu-11 antigens. (1985) (43)
Specific hla‐dqa and hla‐drb1 alleles confer susceptibility to sjögren's syndrome and autoantibody production (1991) (42)
Detection of Epstein-Barr virus and human herpes virus type 6 in saliva from patients with lymphoproliferative diseases by the polymerase chain reaction. (1991) (42)
Epidemiology, pathogenesis, animal models, and treatment of Sjögren's syndrome (1994) (41)
Characterization of the phenotype and function of lymphocytes infiltrating the salivary gland in patients with primary Sjogren syndrome. (1983) (40)
Treatment of Sjögren's syndrome: current therapy and future directions. (2021) (40)
Ecto-5'-nucleotidase activity in human T cell subsets. Decreased numbers of ecto-5'-nucleotidase positive cells from both OKT4+ and OKT8+ cells in patients with hypogammaglobulinemia. (1983) (40)
The instructor cell for the human procoagulant monocyte response to bacterial lipopolysaccharide is a Leu-3a+ T cell by fluorescence-activated cell sorting. (1983) (38)
Computer Applications in Fermentation Technology: Modelling and Control of Biotechnological Processes (1989) (38)
Viral genomes in lymphomas of patients with Sjögren's syndrome. (1989) (36)
Interferon-gamma-dependent modulation of C3b receptors (CR1) on human peripheral blood monocytes. (1986) (36)
Molecular analysis of the human autoantibody response to alpha-fodrin in Sjögren's syndrome reveals novel apoptosis-induced specificity. (2004) (35)
Epstein-Barr virus and human autoimmune diseases: possibilities and pitfalls. (1988) (35)
Sjogren’s syndrome: evolving therapies (2003) (35)
Moloney virus-induced cell surface antigens and histocompatibility antigens are located on distinct molecules. (1979) (34)
IgG4 levels and plasmablasts as a marker for IgG4-related disease (IgG4-RD) (2014) (33)
Idiotypic and genetic studies of human rheumatoid factors. (1987) (32)
Lack of reactivity of rheumatoid arthritis synovial membrane DNA with cloned Epstein Barr virus DNA probes. (1986) (30)
Characterization of recirculating lymphocytes in rheumatoid arthritis patients: selective deficiency of natural killer cells in thoracic duct lymph. (1984) (29)
Systemic Diseases Associated with Dry Eye (1994) (28)
Characterization of a membrane surface glycoprotein associated with T-cell activation. (1985) (28)
Sjögren's syndrome nuclear antigen B (La): cDNA cloning, structural domains, and autoepitopes. (1989) (28)
Sjögren's syndrome: immunologic and neuroendocrine mechanisms. (1994) (27)
Potential role of Epstein-Barr virus in Sjögren's syndrome. (1987) (26)
Reactivation of Epstein-Barr virus in Sjögren's syndrome (1991) (25)
Use of cevimeline, a muscarinic M1 and M3 agonist, in the treatment of Sjögren's syndrome. (2002) (24)
Epstein-Barr virus in rheumatoid arthritis. (1985) (22)
Laboratory evaluation of patients with Sjögren's syndrome. (1992) (22)
Sjögren's syndrome and primary biliary cirrhosis: presence of autoantibodies to purified mitochondrial 2-OXO acid dehydrogenases. (1990) (20)
Structural similarities in the kappa light chains of human rheumatoid factor paraproteins and serum immunoglobulins bearing a cross-reactive idiotype. (1985) (20)
Thoracic duct drainage in rheumatoid arthritis. (1984) (19)
Sjögren Syndrome: Why Do Clinical Trials Fail? (2016) (19)
Epstein-Barr virus induced lymphoproliferative tumors in severe combined immunodeficient mice are oligoclonal (1992) (18)
Treatment of the patient with Sjögren's syndrome. (1992) (18)
Structural characterization of the human T cell surface antigen (p67) isolated from normal and neoplastic lymphocytes. (1982) (17)
Fractionation of human lymphocyte subpopulations on immunoglobulin coated Petri dishes. (1981) (16)
Immunoglobulin-gene rearrangement in benign lymphoepithelial lesions. (1987) (16)
Epstein-Barr virus induced lymphoproliferative tumors in severe combined immunodeficient mice are oligoclonal. (1992) (16)
Solid-phase selection of human T lymphocyte subpopulations using monoclonal antibodies. (1981) (16)
How Does Leflunomide Modulate the Immune Response in Rheumatoid Arthritis? (1999) (15)
Definition of the high-risk acute lymphoblastic leukemia patient by immunological phenotyping with monoclonal antibodies. (1981) (15)
Molecular interactions in human T-cell-mediated cytotoxicity to Epstein-Barr virus. I. Blocking of effector cell function by monoclonal antibody OKT3. (1982) (15)
Autoantibody production in Sjögren's syndrome: a hypothesis regarding defects in somatic diversification of germ line encoded genes. (1988) (14)
Anti‐Glycosphingolipid autoantibodies in rheumatologic disorders (1994) (14)
Lysis of autologous Epstein-Barr virus-infected B cells by cytotoxic T lymphocytes of rheumatoid arthritis patients. (1982) (14)
Sjogren's syndrome: A persistent clinical problem (1985) (13)
Detection of high levels of human herpes virus-6 DNA in a lymphoma of a patient with Sjögren's syndrome. (1993) (13)
Fifth international symposium on Sjögren's syndrome. (1996) (12)
Extraglandular Manifestations of Sjögren’s Syndrome (SS): Dermatologic, Arthritic, Endocrine, Pulmonary, Cardiovascular, Gastroenterology, Renal, Urology, and Gynecologic Manifestations (2011) (11)
Sjögren's syndrome. Pathogenesis and new approaches to therapy. (1998) (11)
Oral problems in patients with Sjögren's syndrome. (1986) (11)
The importance of minor salivary gland biopsy in prediction of lymphoma in Sjögren's syndrome: should we be obtaining more information about prognosis from minor salivary gland samples? (2011) (10)
Is salivary gland ultrasonography a useful tool in Sjögren's syndrome? (2016) (10)
A serologic comparison of Moloney lymphoma cell surface and Moloney oncornavirus antigens. (1979) (10)
Sjögren's syndrome: Infections that may play a role in pathogenesis, mimic the disease, or complicate the patient's course (2011) (10)
Molecular basis for the cross-reactive idiotypes on human anti-IgG autoantibodies (rheumatoid factors). (1987) (9)
The Salivary Gland Epithelial Cell in Sjögren’s Syndrome: What Are the Steps Involved in Wounding or Killing Their Secretory Function? (2012) (9)
Standardisation of labial salivary gland biopsies in Sjogren's syndrome: importance for the practicing rheumatologist (2017) (9)
Fleas Feed on Lizards in the Laboratory in Puerto Rico. (1966) (8)
Lymphoproliferative disease in scid mice reconstituted with human Sjögren's syndrome lymphocytes (1993) (8)
Punctal occlusion for the treatment of dry eye. (1998) (7)
The exocytosis of polymorphonuclear-leukocyte lysosomal enzymes induced by cytochlasin B. (1972) (7)
Summary of the IVth International Sjögren's Syndrome Meeting. (1994) (7)
Immunotactoid-like endoneurial deposits in a patient with monoclonal gammopathy of undetermined significance and neuropathy (2004) (7)
Use of dna amplification methods for clinical diagnosis in autoimmune diseases (1989) (7)
Nucleotide sequence of a uniquely expressed human T cell receptor β chain variable region gene (Vβ) in Siogren's Syndrome (1989) (7)
The distinct pathogenesis of IgG4 Mickulicz's disease and Sjogren's syndrome in Japan; the role of IL-21 and IL-6 (2012) (6)
Establishment of Salivary Gland Epithelial Cell Lines from Patients with Sjogren’s Syndrome and Normal Individual (1989) (5)
Inverse proportions of activated and CD4 circulating lymphocytes in AIDS patients. (1999) (5)
Elements of the Human Immune System: Studies of Mature Lymphoid Cells Following Xenotransplantation to Scid Mice (1989) (5)
Rheumatoid factors in human autoimmune disease: their origin, development and function. (1986) (5)
Characterization of a crossreactive idiotype in Sjögren's syndrome. (1986) (5)
Cell Surface Antigens on Normal and Neoplastic Human Lymphoid Cells (1982) (4)
Summary of the Third International Sjögren's Syndrome Symposium. (2010) (3)
Identification of Generalised (AA) Amyloidosis in an Arabian Gazelle (Gazella gazella sp.) (2001) (3)
Computers and microprocessors in industrial fermentation (1984) (3)
The diversity and idiotypic patterns of human rheumatoid factors in disease. (1988) (3)
Surfactant Protein D Family: Potential for Diagnosis or Monitoring Therapy in Autoimmune Diseases? (2015) (2)
Therapy of Oral and Cutaneous Dryness Manifestations in Sjögren’s Syndrome (2011) (2)
Leflunomide in the treatment of rheumatoid arthritis and other autoimmune disorders (2004) (2)
Management of Sjögren's (2019) (2)
Overview of Management of Dry Eye Associated with Sjögren’s Syndrome (2011) (2)
Absence of unexpected H-2 alloantigens on a murine lymphoma. (1979) (2)
The Neurological Manifestations of Sjögren’s Syndrome: Diagnosis and Treatment (2011) (1)
Human T-lymphocyte Activation Is Associated with Changes in 0-Glycan Biosynthesis* (2001) (1)
Sjögren's syndrome: perspectives on pathogenesis and therapy (2009) (1)
Sjögren’s Syndrome: Interface of Immunology and Neurology (2019) (1)
The value of noninvasive studies of parotid glands in primary Sjögren's syndrome. (2001) (1)
Nucleotide sequence of a uniquely expressed human T cell receptor beta chain variable region gene (V beta) in Sjogren's syndrome. (1989) (1)
Sjögren's syndrome. (1995) (1)
Should we be using organ-specific antigens to understand organ-specific autoimmune disease? (2013) (1)
Impact of Systemic Immune Disease on the Lacrimal Functional Unit (2004) (1)
Staining and fluorescence-activated cell sorter analysis of human lymphocytes using antibodies to a short, chemically synthesized human IL-2 peptide. (1985) (1)
Sjögren Syndrome: The Association of Keratoconjunctivitis sicca and Interstitial Nephritis1 (1993) (1)
Rheumatoid Factor in Sjögren’s Syndrome (1987) (1)
6 Sjögren ’ s Syndrome : An Immunological Perspective (2011) (1)
The distinct pathogenesis of IgG 4 Mickulicz ’ s disease and Sjogren ’ s syndrome in Japan ; the role of IL-21 and IL-6 (2012) (1)
26. A case of Rottweiler lukoencephalomyelopathy (2003) (0)
Analysis of Peripheral Blood and Salivary Gland Lymphocytes in Sjogren’s Syndrome (1983) (0)
Epstein-Barr Virus Induced Lymphoproliferative Tumors in Severe Combined Immunodeficient Mice Are Oligoclonal By Pave 1 Pisa (2003) (0)
Autoantibodies and Autoantigens in Sjögren’s Syndrome (2016) (0)
RANDOMIZED, PLACEBO CONTROLLED TRIAL OF CEVIMELINE, A NOVEL M-3 MUSCARINIC RECEPTORAGONIST, FOR THE TREATMENT OF SJOGREN'S SYNDROME. (2000) (0)
Cl in ic ian ’ s Corner Systemic Activity at Diagnosis of Sjögren ’ s : A Key Prognostic Marker (2015) (0)
Immunopolypeptides diriges contre le virus de l'hepatite c (2002) (0)
Comprar Sjögren’s Syndrome | Fox, Robert I. | 9781603279567 | Springer (2011) (0)
SSF Clinical Practice Guidelines for Caries Prevention are Here ! (2016) (0)
Genetic polymorphisms and DNA sequences of T-cell antigen receptors and histocompatible antigen genes in primary Sjogren's syndrome (1989) (0)
[Relationship between HLA D region gene and primary Sjögren's syndrome]. (1991) (0)
Practical Approach to Treatment of Sjögren ' s Syndrome – Dry Mouth and Gynecologic Complaints (2013) (0)
Therapy of Dermatologic, Renal, Cardiovascular, Pulmonary, Gynecologic, Gastro-enterologic, Urologic and Fibromyalgia Manifestations Including Special Considerations at the Time of Surgery (2011) (0)
Myths, Pearls, and Tips Regarding Sjögren’s Syndrome (2011) (0)
Characterization of Lymphocytes in Tissue Lesions from Patients with Rheumatoid Arthritis and Sjögren’s Syndrome Using Monoclonal Antibody SC1 (1984) (0)
List of Contributors (2019) (0)
NeutraSal ® is clinically proven to help restore the oral environment 2 FOR PATIENTS WITH SJÖGREN ’ S SYNDROME 90 % OF PATIENTS REPORTED IMPROVEMENT IN SWALLOWING (2017) (0)
X-linked genes exhibit skewed expression in Sjogren’s disease (SjD): a further step toward understanding the female predominance of autoimmune disease (2022) (0)
Proteomics, Saliva, and Sjögren's Syndrome (2008) (0)
Clinical Syndromes Associated with Epstein-Barr Virus (1989) (0)
Section Reviews: Biologicals & Immunologicals: Sjögren's syndrome: Pathogenesis and prospects for therapy (1996) (0)
Axial Articular Manifestations in Primary Sjögren Syndrome: Have We Been Missing Spondyloarthritis for All This Time? (2021) (0)
Endoscopic Ultrasound :An Introductory Manual and Atlas, Second Edition (2012) (0)
Modulation of complement c 3b receptors on human monocytes by interferon gamma (1985) (0)
Pearls of Wisdom and Myths Regarding Sjögren ’ s Syndrome (2010) (0)
HUMAN HOMINIVOROX MYIASIS IN PUERTO RICO. (1965) (0)
Top Stories 7 Clinician ’ s Corner – Nail Capillaroscopy in SS 9 New Partnerships for 2010 SSF Student Fellowships 15 Patient Education – Anti-Inflammatory Diet (2010) (0)
Monoclonal antibodies useful for diagnosis and treatment of squamous oral carcinoma (1988) (0)
干燥综合征分类标准：美国-欧洲合意小组制定的欧洲标准修订版 (2004) (0)
Antiphospholipid antibodies and HLA associations in primary S jogren ' s syndrome (0)
The Role of the Immune System in the Pathogenesis of Lupus (2010) (0)
Detection of viral genomes in lymphomas arising Sjogren's syndrome (1989) (0)
Synthetic polypeptide and its use for diagnosis of the Epstein-Barr virus, and the synthetic polypeptide oligomer synthesis w (1987) (0)
Sjeogren's syndrom (2013) (0)
Arthritis and Rheumatism Proteomic Study of Salivary Peptides and Proteins in Patients with Sjögren ' s Syndrome Before and After Pilocarpine Treatment (2009) (0)
New Developments in Laboratory Tests and Therapy for Rheumatoid Arthritis (2002) (0)
Alterations in Corneal Nerve Fiber Density and Pain Markers during the Progression of Desiccating Stress-Induced Dry Eye Disease (2012) (0)
The Professionals ’ Resource on Sjögren ’ s Syndrome First Genetic Associations Established for Sjögren ’ s (2014) (0)
Shared Pathogenetic Features Between Common Variable Immunodeficiency and Sjögren’s Syndrome: Clues for a Personalized Medicine (2021) (0)
Decreased T cell ecto-5'-nucleotidase activity in agammaglobulinemia patients is not due to altered proportions of helper and suppressor T cells as defined by the monoclonal antibodies OKT4 and OKT8. (1984) (0)
SJÖGREN ’ S SYNDROME : A GUIDE FOR THE PATIENT (2003) (0)
1 Towards Small Molecules in the Treatment of Sjögren ’ s Syndrome : Current Therapy and Future Directions (2018) (0)
DÃ©finitionof the High-Risk Acute Lymphoblastic Leukemia Patient by Immunological Phenotyping with Monoclonal Antibodies1 (2006) (0)
Updates in Sjögren Syndrome (2018) (0)
A cross reactive idiotype on rheumatoid factor is found in Sjogren's syndrome patients in different parts of the world (1989) (0)
Mice with Desiccating Stress-Induced Dry Eye Develop Trigeminal Neuralgia, Despite Decreased Corneal Sensitivity and Nerve Fiber Degeneration (2013) (0)
Providing Information to Referring Physicians and Patients (2011) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Robert Irving Fox?

Robert Irving Fox is affiliated with the following schools:

Stanford University

Robert Irving Fox's Academic­Influence.com Rankings

Robert Irving Fox's Degrees

Why Is Robert Irving Fox Influential?

Robert Irving Fox's Published Works

Published Works

What Schools Are Affiliated With Robert Irving Fox?

Robert Irving Fox's AcademicInfluence.com Rankings